N-((2-Methoxypyridin-3-yl)methyl)cyclopentanamine

Catalog No.: 
ACOETA432
CAS No.: 
1184740-09-7
Molecular Formula: 
C12H18N2O
Molecular Weight: 
206.29
N-((2-Methoxypyridin-3-yl)methyl)cyclopentanamine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$148.00InquiryInquiry
1g95%$443.00InquiryInquiry
5g95%$1288.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-((2-Methoxypyridin-3-yl)methyl)cyclopentanamine
IUPAC NameN-((2-methoxypyridin-3-yl)methyl)cyclopentanamine
Molecular FormulaC12H18N2O
Molecular Weight206.29
SMILESCOC1=NC=CC=C1CNC2CCCC2
InChI KeyMRDLILOVLHRIQP-UHFFFAOYSA-N
Synonym3-Pyridinemethanamine, N-cyclopentyl-2-methoxy-;n-[(2-methoxypyridin-3-yl)methyl]cyclopentanamine
CAS No.1184740-09-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACOETA432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOPMN287 route compound structure diagram
    ACOPMN28771255-09-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOETA432 route product structure diagram
    ACOETA4321184740-09-7
Inquiry

2. ACOETA432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAHKL238 route compound structure diagram
    ACAHKL238354824-19-4In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACOETA432 route product structure diagram
    ACOETA4321184740-09-7
Inquiry

3. ACOETA432 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOETA432 route product structure diagram
    ACOETA4321184740-09-7
Inquiry

Comments (0)